From 16 to 19 May 2023, the specific program of P+F Products + Features GmbH in the forthcoming Euro PCR 2023 will be held at the Palais des Congrès in Paris.
Untreated severe symptomatic tricuspid valve regurgitation is associated with significant morbidity and mortality. When surgical correction is not feasible due to high operative risk, transcatheter tricuspid valve treatment has been suggested as an attractive value option.
Prof. Gaspardone spoke on LA7 to talk about the innovative Noblestitch device
The coronary stent, invented by Julio Palmaz in 1987, was defined by the prestigious IP Worldwide Magazine as one of the ten inventions of the 20th century that helped change the world.
The NOBLESTICH EL system produced by Nobles Medical Technology II USA, used by Umberto I of Rome.
